365 related articles for article (PubMed ID: 33655866)
1. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
[TBL] [Abstract][Full Text] [Related]
2. Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
Malm H; Brown AS; Gissler M; Gyllenberg D; Hinkka-Yli-Salomäki S; McKeague IW; Weissman M; Wickramaratne P; Artama M; Gingrich JA; Sourander A
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):359-66. PubMed ID: 27126849
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
Morales DR; Slattery J; Evans S; Kurz X
BMC Med; 2018 Jan; 16(1):6. PubMed ID: 29332605
[TBL] [Abstract][Full Text] [Related]
6. In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis.
Halvorsen A; Hesel B; Østergaard SD; Danielsen AA
Acta Psychiatr Scand; 2019 Jun; 139(6):493-507. PubMed ID: 30937904
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
[TBL] [Abstract][Full Text] [Related]
8. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
[TBL] [Abstract][Full Text] [Related]
9. Bipolar women's antepartum psychotropic exposure and offspring risk of attention-deficit/hyperactivity disorder and autism spectrum disorder.
Yeh TC; Bai YM; Hsu JW; Huang KL; Tsai SJ; Chu HT; Liang CS; Chen MH
J Affect Disord; 2021 Dec; 295():1407-1414. PubMed ID: 34565590
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
Masarwa R; Platt RW; Filion KB
Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
[TBL] [Abstract][Full Text] [Related]
13. Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: A systematic review and meta-analysis.
Huang W; Page RL; Morris T; Ayres S; Ferdinand AO; Sinha S
PLoS One; 2023; 18(11):e0294996. PubMed ID: 38019759
[TBL] [Abstract][Full Text] [Related]
14. Maternal exposure to pesticides and autism or attention-deficit/hyperactivity disorders in offspring: A meta-analysis.
Xu Y; Yang X; Chen D; Xu Y; Lan L; Zhao S; Liu Q; Snijders AM; Xia Y
Chemosphere; 2023 Feb; 313():137459. PubMed ID: 36470360
[TBL] [Abstract][Full Text] [Related]
15. Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.
Tadesse AW; Dachew BA; Ayano G; Betts K; Alati R
J Psychiatr Res; 2024 Mar; 171():142-151. PubMed ID: 38281464
[TBL] [Abstract][Full Text] [Related]
16. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
[TBL] [Abstract][Full Text] [Related]
17. Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review.
Nanjappa MS; Voyiaziakis E; Pradhan B; Mannekote Thippaiah S
CNS Spectr; 2022 Jun; 27(3):290-297. PubMed ID: 33280640
[TBL] [Abstract][Full Text] [Related]
18. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
[TBL] [Abstract][Full Text] [Related]
19. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
20. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors.
Engler J; Filliter C; Montastruc F; Abenhaim H; Rej S; Renoux C
J Affect Disord; 2024 Apr; 350():813-821. PubMed ID: 38246277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
